Haifeng Lu
- Molecular Biology top 5%
- Epidemiology top 2%
- Infectious Diseases top 2%
- Oncology top 5%
- Physiology top 5%
- Topics
- Gut microbiota and health (32 papers)Clostridium difficile and Clostridium perfringens research (14 papers)Liver Disease Diagnosis and Treatment (13 papers)
- Partner nations
- ChinaMadagascarNetherlands
In The Last Decade
Haifeng Lu
61 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 2.5k
- Epidemiology 1.4k
- Infectious Diseases 795
- Oncology 604
- Physiology 594
Countries citing papers authored by Haifeng Lu
This map shows the geographic impact of Haifeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Lu more than expected).
Fields of papers citing papers by Haifeng Lu
This network shows the impact of papers produced by Haifeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Lu. The network helps show where Haifeng Lu may publish in the future.
Co-authorship network of co-authors of Haifeng Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Lu. A scholar is included among the top collaborators of Haifeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Lu. Haifeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | Characterization of the TCR β Chain Repertoire in Peripheral Blood from Hepatitis B Vaccine Responders and Non-Responders | 7 |
| 5 | 20 | |
| 6 | 12 | |
| 7 | 5 | |
| 8 | 103 | |
| 9 | 21 | |
| 10 | Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinomabreakdown → | 543 |
| 11 | 11 | |
| 12 | 20 | |
| 13 | 25 | |
| 14 | 77 | |
| 15 | 65 | |
| 16 | 42 | |
| 17 | 178 | |
| 18 | 14 | |
| 19 | Characterization of fecal microbial communities in patients with liver cirrhosisbreakdown → | 801 |
| 20 | ERIC-PCR based fingerprinting and molecular hybridization to analyze the characteristics of intestinal microflora of giant panda | 3 |
About Haifeng Lu
Haifeng Lu is a scholar working on Hepatology, Molecular Medicine and Infectious Diseases, having authored 62 papers that have together received 3.8k indexed citations. Recurring topics across this work include Gut microbiota and health (32 papers), Clostridium difficile and Clostridium perfringens research (14 papers) and Liver Disease Diagnosis and Treatment (13 papers). The work is most often cited by research in Hepatology (517 citations), Infectious Diseases (795 citations) and Epidemiology (1.4k citations). Haifeng Lu has collaborated with scholars based in China, Madagascar and Netherlands. Frequent co-authors include Lanjuan Li, Yunbo Chen, Yanfei Chen, Shusen Zheng, Zhigang Ren, Fengling Yang, Baohong Wang, Baoli Zhu, Yuezhu Wang and Dajiang Lei. Their work appears in journals such as PLoS ONE, Hepatology and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.